Q2 2017 Holdings
Filed 2017-08-14 | 71 holdings | $53.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $19.5M | 720,000 | 36.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $10.0M | 125,000 | 18.6% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $8.9M | 620,300 | 16.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $7.3M | 1,422,738 | 13.6% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $3.8M | 300,000 | 7.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.6M | 230,000 | 6.7% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $50.6K | 900,000 | 0.1% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $37.8K | 950,000 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $28.9K | 275,000 | 0.1% |
| Quotient LTD | SHS | G73268107 | $26.1K | 3,549,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $25.9K | 1,300,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $22.9K | 300,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $22.4K | 750,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $20.1K | 270,000 | 0.0% |
| Anaptysbio(ANAB) | COM | 032724106 | $19.1K | 799,469 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $18.6K | 367,900 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $17.8K | 3,804,027 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $17.7K | 1,940,880 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $17.7K | 1,997,412 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $15.8K | 200,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $15.5K | 1,500,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $13.1K | 1,000,000 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $12.3K | 952,798 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $11.5K | 250,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $10.3K | 900,000 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $8.4K | 479,986 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $7.9K | 570,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $7.5K | 900,000 | 0.0% |
| Audentes Therapeutics, Inc(BOLDEUR) | COM | 05070R104 | $6.2K | 323,545 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.7K | 500,000 | 0.0% |
| Synergy Pharmaceuticals Inc | COM NEW | 871639308 | $5.3K | 1,200,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $5.1K | 3,550,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.1K | 70,000 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $5.1K | 700,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $5.0K | 359,738 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $5.0K | 170,000 | 0.0% |
| Fulgent Genetics Inc(FLGT) | COM | 359664109 | $4.8K | 750,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $4.8K | 296,296 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $4.7K | 1,200,000 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $4.7K | 1,250,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $4.6K | 809,804 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $4.2K | 1,539,750 | 0.0% |
| Curis Inc | COM | 231269101 | $3.8K | 2,000,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $3.8K | 202,079 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $3.5K | 400,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $3.4K | 1,690,800 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $3.3K | 337,000 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $3.0K | 741,496 | 0.0% |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | $2.9K | 75,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $2.6K | 600,000 | 0.0% |